This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Mustafa C. Karakus
Associate Vice President
Contact
MustafaKarakus@517b2b.comOverview
Mustafa C. Karakus, PhD, is an Associate Vice President for Social Policy and Economics Research and a health economist with extensive experience designing and conducting social science research, program and policy evaluations, and econometric and cost analyses. His work focuses on health policy and health services research, health care financing, and health outcomes analysis. He also provides subject matter expertise on study design and implementation, data collection oversight, data analysis, and report writing.
Karakus has led numerous survey research, quantitative research, and program evaluation projects for federal clients. His work has centered on evaluating all aspects of federally funded programs and federal policy changes involving vulnerable populations, such as people with serious mental illness, first episode psychosis, or substance use problems; veterans with disabilities; people who are chronically homeless; and Social Security Disability Insurance recipients.
Education
- Postdoctoral Fellowship, Johns Hopkins Center for Prevention and Early Intervention
- PhD, Health Economics, Johns Hopkins University
- MA, Economics, University of Colorado
- BS, Managerial Engineering, Istanbul Technical University, Istanbul, Turkey
-
Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance
Journal of Infectious Diseases
January 2023
C.H. Bozio, K.A. Butterfield, M. Briggs Hagen, S. Grannis, P. Drawz, E. Hartmann, T.C. Ong, et al.
DOILink for: Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance -
Association of trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence and state-issued nonpharmaceutical interventions: United States, 1 August 2020 to 30 March 2021
75,
Clinical Infectious Diseases
January 2022
M.J. Miller, A. Himschoot, N. Fitch, S. Jawalkar, D. Freeman, C. Hilton, K. Berney, et al.
DOILink for: Association of trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence and state-issued nonpharmaceutical interventions: United States, 1 August 2020 to 30 March 2021 -
Advancing multi-level health communication research: A delphi study on barriers and opportunities
Translational Behavioral Medicine
January 2022
A.Y. Oh, C.J. Rising, A. Gaysynsky, Sophia Tsakraklides, G.C. Huang, W.-Y.S. Chou, K.D. Blake, et al.
DOILink for: Advancing multi-level health communication research: A delphi study on barriers and opportunities